37 related articles for article (PubMed ID: 22734033)
1. Combined Germline and Mosaic SDHA Mutation Is Associated With a Multicancer Syndrome Including Neuroblastoma, Renal Cancer, and Multifocal GI Tumor.
Cranmer LD; Konnick EQ; Yoshida JR; Jacobson AL; Malik BA; Mogal H; Sullivan LB; Handfrod CL; Pritchard CC; Dubard-Gault ME
JCO Precis Oncol; 2024 Jun; 8():e2300455. PubMed ID: 38885448
[TBL] [Abstract][Full Text] [Related]
2. Papillary Renal Cell Carcinoma in Lynch/Muir-Torre Syndrome with Germline Pathogenic Variant in
Yang Y; Dhar S; Taylor J; Krishnan B
J Kidney Cancer VHL; 2021; 8(2):8-19. PubMed ID: 33977078
[TBL] [Abstract][Full Text] [Related]
3. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.
McCarthy AJ; Capo-Chichi JM; Spence T; Grenier S; Stockley T; Kamel-Reid S; Serra S; Sabatini P; Chetty R
J Pathol Clin Res; 2019 Apr; 5(2):115-129. PubMed ID: 30387329
[TBL] [Abstract][Full Text] [Related]
4. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.
Stratton KL; Alanee S; Glogowski EA; Schrader KA; Rau-Murthy R; Klein R; Russo P; Coleman J; Offit K
Urol Oncol; 2016 May; 34(5):238.e1-7. PubMed ID: 26723226
[TBL] [Abstract][Full Text] [Related]
5. The role of immunohistochemistry in the Muir-Torre Syndrome.
Oliveira CM; Campos JG; Maia MR; Lobo LE; Valle FF
An Bras Dermatol; 2015; 90(3 Suppl 1):168-70. PubMed ID: 26312706
[TBL] [Abstract][Full Text] [Related]
6. Muir-Torre syndrome: case report and molecular characterization.
Rios CA; Villalón R; Muñoz J; Acuña M; Cifuentes L
Sao Paulo Med J; 2014; 132(1):61-4. PubMed ID: 24474082
[TBL] [Abstract][Full Text] [Related]
7. [Sebaceous gland tumor with a rare gene mutation within a tumor syndrome: Muir-Torre syndrome].
Voigt E; Sommer F; Geiger KD; Pillunat LE
Ophthalmologe; 2014 Apr; 111(4):369-72. PubMed ID: 23774967
[TBL] [Abstract][Full Text] [Related]
8. Muir-Torre Syndrome With a Frame-shift Mutation in the MSH2 Gene: A Rare Case Report and Literature Review.
Chen Q; Wang M; Xu Z; Wang M; Jin S; Tian S; Xiao S
Int J Gynecol Pathol; 2020 Mar; 39(2):136-140. PubMed ID: 32039937
[TBL] [Abstract][Full Text] [Related]
9. Germline mutation in MSH6 associated with multiple malignant neoplasms in a patient With Muir-Torre syndrome.
Tavakkol Z; Keller JJ; Furmanczyk PS; Bennett RL; Chien AJ
J Clin Oncol; 2012 Aug; 30(22):e195-8. PubMed ID: 22734033
[No Abstract] [Full Text] [Related]
10. MSH6 mutation in a family affected by Muir-Torre syndrome.
Kacerovska D; Cerna K; Martinek P; Grossmann P; Michal M; Ricar J; Kazakov DV
Am J Dermatopathol; 2012 Aug; 34(6):648-52. PubMed ID: 22814321
[TBL] [Abstract][Full Text] [Related]
11. [Muir-Torre syndrome: rare association with duodenal carcinoma].
Bacha D; Deschamps L; Sauvanet A; Couvelard A
Ann Pathol; 2009 Dec; 29(6):495-8. PubMed ID: 20005439
[TBL] [Abstract][Full Text] [Related]
12. MSH6, Past and Present and Muir-Torre Syndrome-Connecting the Dots.
Mahalingam M
Am J Dermatopathol; 2017 Apr; 39(4):239-249. PubMed ID: 28323777
[TBL] [Abstract][Full Text] [Related]
13. [Sebaceous tumors and Muir-Torre syndrome].
Bourlond F; Cribier B; Lipsker D; Velter C
Ann Dermatol Venereol; 2015; 142(6-7):456-9. PubMed ID: 25890836
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]